Beta interferons and glatiramer acetate for treating multiple sclerosis
Technology appraisal guidance
Reference number: TA527
Published:
The MTA ‘Multiple sclerosis - interferon beta, glatiramer acetate (review TA32) [ID809]’ has been suspended to allow NICE to reconcile the submissions made by stakeholders and the Assessment Group with the committee’s preferred assumptions.